Navin Kumar Sinha
Navin Kumar Sinha has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Abha Soni
National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi 110029, India
1 shared publication - Chintamani Chintamani
Sir Gangaram Hospital, New Delhi, India
1 shared publication - Dinesh Bhatnagar
Department of Surgery, Safdarjung Hospital Campus, New Delhi 110029, India
1 shared publication - Manoj Kumar
Lab for Molecular Reproduction and Genetics, Anatomy department, All India Institute of medical Sciences, New Delhi, India
1 shared publication - Meena Lakhanpal
National Institute of Pathology (ICMR), Safdarjung Hospital Campus, New Delhi 110029, India
1 shared publication - Ravindar Singh Mohil
Department of Surgery, Safdarjung Hospital Campus, New Delhi 110029, India
1 shared publication
Latest Publications
- Open Access
- 1 April 2015
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 9 (4) , ED01-2
Paratesticular Rhabdomyosarcoma in Young Adult- A Case Report
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.
- 1 April 2015
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 9 (4) , ED01-2
Open AccessParatesticular Rhabdomyosarcoma in Young Adult- A Case Report
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.
- Open Access
- 5 February 2014
- Published by Springer Nature in Cancer Cell International
- Vol. 14 (1) , 14
Establishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis
Two novel triple negative breast cancer cell lines, NIPBC-1 and NIPBC-2 were successfully established from primary tumors of two young breast cancer patients aged 39 and 38 years respectively, diagnosed as infiltrating duct carcinoma of breast. Characterization of these cell lines showed luminal origin with expression of epithelial specific antigen and cytokeratin 18 and presence of microfilaments and secretary vesicles, microvilli, tight junctions and desmosomes on ultra-structural analysis. Both the cell lines showed anchorage independent growth and invasion of matrigel coated membranes. Karyotype analysis showed aneuploidy, deletions and multiple rearrangements in chromosomes 7, 9, X and 11 and isochromosomes 17q in both the cell lines. P53 mutational analysis revealed no mutation in the coding region in both the cell lines; however NIPBC-2 cell line showed presence of heterozygous C/G polymorphism, g.417 C > G (NM_000546.5) resulting in Arg/Pro allele at codon 72 of exon 4. Screening for mutations in BRCA1&2 genes revealed presence of three heterozygous polymorphisms in exon 11 of BRCA1 and 2 polymorphisms in exons 11, and14 of BRCA2 gene in both the cell lines. Both the cell lines showed presence of CD 44+/24-breast cancer stem cells and capability of producing mammosphere on culture. The two triple negative breast cancer cell lines established from early onset breast tumors can serve as novel invitro models to study mechanisms underlying breast tumorigenesis in younger age group patients and also identification of new therapeutic modalities targeting cancer stem cells.
- 5 February 2014
- Published by Springer Nature in Cancer Cell International
- Vol. 14 (1) , 14
Open AccessEstablishment and characterization of two primary breast cancer cell lines from young Indian breast cancer patients: mutation analysis
Two novel triple negative breast cancer cell lines, NIPBC-1 and NIPBC-2 were successfully established from primary tumors of two young breast cancer patients aged 39 and 38 years respectively, diagnosed as infiltrating duct carcinoma of breast. Characterization of these cell lines showed luminal origin with expression of epithelial specific antigen and cytokeratin 18 and presence of microfilaments and secretary vesicles, microvilli, tight junctions and desmosomes on ultra-structural analysis. Both the cell lines showed anchorage independent growth and invasion of matrigel coated membranes. Karyotype analysis showed aneuploidy, deletions and multiple rearrangements in chromosomes 7, 9, X and 11 and isochromosomes 17q in both the cell lines. P53 mutational analysis revealed no mutation in the coding region in both the cell lines; however NIPBC-2 cell line showed presence of heterozygous C/G polymorphism, g.417 C > G (NM_000546.5) resulting in Arg/Pro allele at codon 72 of exon 4. Screening for mutations in BRCA1&2 genes revealed presence of three heterozygous polymorphisms in exon 11 of BRCA1 and 2 polymorphisms in exons 11, and14 of BRCA2 gene in both the cell lines. Both the cell lines showed presence of CD 44+/24-breast cancer stem cells and capability of producing mammosphere on culture. The two triple negative breast cancer cell lines established from early onset breast tumors can serve as novel invitro models to study mechanisms underlying breast tumorigenesis in younger age group patients and also identification of new therapeutic modalities targeting cancer stem cells.
- Open Access
- 1 January 2014
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 8 (3) , 140-1
Struma Ovarii with Elevated Ca-125 Levels and Ascites Mimicking Advanced Ca Ovary
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.
- 1 January 2014
- Published by JCDR Research and Publications in Journal of Clinical and Diagnostic Research
- Vol. 8 (3) , 140-1
Open AccessStruma Ovarii with Elevated Ca-125 Levels and Ascites Mimicking Advanced Ca Ovary
Journal of Clinical and Diagnostic Research aims to publish findings of doctors at grass root level and post graduate students, so that all unique medical experiences are recorded in literature.